Navigation Links
aTyr Pharma to Present at BioPharm America 2009
Date:9/14/2009

SAN DIEGO, Sept. 14 /PRNewswire/ -- aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPharm America 2009 conference in San Francisco, CA on Friday, September 18th. Jeff Watkins, CEO of aTyr Pharma, will present an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases. The aminoacyl tRNA synthetases are universal and essential elements of the protein synthesis machinery found in all organisms, but human synthetases and their associated proteins have naturally occurring resected variants, called "resectins," with potent cell signaling activities that are vital to normal functioning of humans. The resectins' activities are distinct from the protein synthesis activities commonly known for synthetases, and aTyr Pharma is discovering and developing the resectins as new biotherapeutic agents that can be used to treat a wide variety of human diseases including inflammatory, autoimmune, hematopoietic and metabolic disorders.

According to Cheryl Quinn, Director of Business Development at aTyr Pharma, "Because our product engine is based on the emerging new science of resectin proteins, we look forward to introducing aTyr Pharma's exciting new science and portfolio to the attendees of BioPharma America."

About aTyr Pharma

aTyr Pharma, Inc. is a biopharmaceutical company focused on the discovery and development of an entirely new class of biologics. aTyr Pharma's discovery engine for new biotherapeutics consists of novel proteins in the family of tRNA synthetases with cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These resected proteins, or "resectins," are being developed as novel therapeutics to treat he
'/>"/>

SOURCE aTyr Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Tobira Therapeutics Inc. Announces Phase I Pharmacokinetic Data of TBR-652 for the Treatment of HIV
2. Pharmacyclics Announces Date of Fourth Quarter and Fiscal Year End 2009 Conference Call
3. Enox Biopharma Will Present Its Unique Self-Sterilizing Urinary Catheter at the 49th Annual ICAAC Meeting.
4. NexGenix Pharmaceuticals to Present at Two Industry Conferences: Rodman & Renshaw 11th Annual Healthcare Conference and Life Sciences Summit 2009
5. ISTA Pharmaceuticals to Present at NewsMakers in the Biotech Industry Conference
6. StoredIQ Shares Expertise at IQPCs eDiscovery Pharma, Biotech and Medical Device Conference
7. Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan
8. Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin(R) (MP-376) Treatment in Cystic Fibrosis Patients
9. Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
10. Rib-X Pharmaceuticals to Present at the 49th ICAAC
11. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Bill Jacobs Automotive, a group of car ... up with the Heartland Blood Center and offering free oil ... drive takes place Saturday, Jan. 18 at the Bill Jacobs ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46637 )  The ...
(Date:1/15/2014)... FALLS, N.Y., Jan. 15, 2014   Niagara Thermal Products ... selected by Buffalo BioBlower Technologies LLC ("B3") as the ... Phase 2 award from the Army Corps of Engineers.  ... that kills all biological contaminants and destroys VOCs and ...
(Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused on ... of tumor cells in the bloodstream, today announced that ... support application powered by CollabRx, Inc. , Available ... Therapy Finder will provide breast cancer patients and their ...
(Date:1/15/2014)... 15, 2014 ­ RedBrick Health , a fast-growing ... today announces that EmblemHealth , the ... is now providing the RedBrick Compass health assessment, combined ... all of its members. EmblemHealth is among the first ...
Breaking Biology Technology:Join the Bill Jacobs Auto blood drive and receive a free oil change 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3
... N.J., March 24 Osteotech, Inc.,(Nasdaq: OSTE ... biologic solutions for,regenerative medicine, announced today that the ... validity of its U.S. Patent No.,5,676,146. The ,146 ... demineralized bone, with a radiopaque material, such as ...
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), http://www.geovax.com, ... pleased to announce the addition of Dr. Robert,McNally as ... company co-founder Don Hildebrand remains as Chairman of the ... involved in company,development, growth and expansion plans in the ...
... Stock Exchange Symbol: MS, EDMONTON, March 24 /PRNewswire-FirstCall/ ... the treatment of multiple sclerosis (MS), today,announced that Mr. ... "Future Leaders in the Biotech Industry" Conference in New ... at 2:00pm (Eastern Time), WHERE: The Millennium ...
Cached Biology Technology:U.S. Patent Office Confirms Validity of Osteotech's U.S. Patent No. 5,676,146 2GeoVax Further Strengthens Management Team 2GeoVax Further Strengthens Management Team 3GeoVax Further Strengthens Management Team 4GeoVax Further Strengthens Management Team 5BioMS Medical to present at BioCentury Conference 2
(Date:4/22/2014)... solar material that has the same crystal structure as ... 1839 is shooting up the efficiency charts faster than ... optimism that a less expensive way of using sunlight ... , Researchers at the Energy Department,s National Renewable Energy ... the lab,s unique testing capabilities and broad spectrum of ...
(Date:4/22/2014)... Telling someone to "act your age" is another way ... however, does not always bring improvements. Certain cells of ... the elderly more vulnerable to illness. Because these cells ... studying the effects of microgravity on immune cells to ... age. , NASA and the National Institute on Aging, ...
(Date:4/22/2014)... the development of the heart only happens in the womb, ... cellular changes that play a role in the structure and ... College of Medicine have now been able to categorize the ... their role) that takes place during these changes and what ... in Nature Communications , also helped to identify a ...
Breaking Biology News(10 mins):NREL unlocking secrets of new solar material 2NREL unlocking secrets of new solar material 3NREL unlocking secrets of new solar material 4NREL unlocking secrets of new solar material 5NREL unlocking secrets of new solar material 6For an immune cell, microgravity mimics aging 2For an immune cell, microgravity mimics aging 3For an immune cell, microgravity mimics aging 4For an immune cell, microgravity mimics aging 5Protein expression gets the heart pumping 2
... major food source for much of the world, rice is one ... from disease has become, in part, the task of a group ... State University. The researchers are looking at two bacterial diseases ... is caused by a bacterium called Xanthomonas oryzae pathovar oryzae ...
... N.Y. (Wednesday, April 1, 2009) Along with new ... home to an in-depth library of basic laboratory methods. ... of these standard techniques. From molecular biology researchers ... is the commonly used method for nucleic acid amplification. ...
... (SACRAMENTO, Calif.) New research from UC Davis Cancer Center ... ingredient that allows breast cancer to spread to other organs ... April 1 issue of Cancer Research , is one ... the disease. Kermit Carraway, senior author of the study, ...
Cached Biology News:Researchers examine bacterial rice diseases, search for genetic solutions 2Basic guides to PCR, labeling neurons featured in Cold Spring Harbor Protocols 2UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs 2
... high performance miniature stepper motors available in ... frame sizes. These space-efficient 1.8 2-phase stepper ... including medical instrumentation, medical devices, drug discovery ... Meets a wide range of customer needs ...
... screening project: , 384 Individual ... shape-diverse mixtures of 4 (5 uL each) , ... Individual compounds are dissolved in DMSO at ca. ... Supplied in 5 96-well trays. Dilute library with protein ...
... the proven features of the pET, BacVector ... all of the benefits and versatility of ... The pTriEx vectors have been extensively tested ... all three expression systems. In each case, ...
... The RapidCycler is the first instrument engineered ... and is used by thousands of research ... LightCycler Capillary tubes which are ideally suited ... thin walls and extremely high surface-area-to-volume ratio. ...
Biology Products: